Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$164.26
+0.2%
$150.71
$93.17
$166.32
$39.14B0.662.24 million shs4.19 million shs
McKesson Corporation stock logo
MCK
McKesson
$721.58
0.0%
$709.57
$464.42
$733.10
$90.31B0.49921,927 shs530,921 shs
ResMed Inc. stock logo
RMD
ResMed
$256.06
+0.6%
$242.35
$180.34
$263.05
$37.32B0.78984,532 shs993,727 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.19%-0.38%+7.55%+22.66%+56.62%
McKesson Corporation stock logo
MCK
McKesson
-0.12%-0.40%+0.86%+8.93%+18.72%
ResMed Inc. stock logo
RMD
ResMed
+0.71%+2.37%+5.36%+15.39%+40.41%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.6064 of 5 stars
2.43.04.23.64.01.71.3
McKesson Corporation stock logo
MCK
McKesson
4.4283 of 5 stars
2.43.03.33.03.02.51.3
ResMed Inc. stock logo
RMD
ResMed
4.1435 of 5 stars
2.31.03.34.62.71.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.79
Moderate Buy$157.43-4.16% Downside
McKesson Corporation stock logo
MCK
McKesson
2.86
Moderate Buy$696.42-3.49% Downside
ResMed Inc. stock logo
RMD
ResMed
2.60
Moderate Buy$259.331.28% Upside

Current Analyst Ratings Breakdown

Latest CAH, MCK, and RMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$166.00 ➝ $181.00
6/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$157.00 ➝ $170.00
6/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00 ➝ $180.00
6/11/2025
McKesson Corporation stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$745.00 ➝ $770.00
6/10/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$165.00 ➝ $170.00
6/3/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$136.00 ➝ $179.00
6/3/2025
McKesson Corporation stock logo
MCK
McKesson
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$691.00 ➝ $766.00
5/20/2025
ResMed Inc. stock logo
RMD
ResMed
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$286.00
5/9/2025
McKesson Corporation stock logo
MCK
McKesson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$755.00 ➝ $800.00
5/5/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$142.00 ➝ $166.00
5/2/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$156.00 ➝ $170.00
(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$226.83B0.17$10.55 per share15.57($13.19) per share-12.45
McKesson Corporation stock logo
MCK
McKesson
$359.05B0.25$38.84 per share18.58($13.52) per share-53.37
ResMed Inc. stock logo
RMD
ResMed
$4.69B8.01$9.28 per share27.58$33.11 per share7.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$852M$6.4125.6318.351.830.70%-68.84%4.21%8/13/2025 (Estimated)
McKesson Corporation stock logo
MCK
McKesson
$3.30B$25.8327.9419.691.440.92%-201.12%5.83%8/6/2025 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.02B$8.9128.7424.721.7526.15%25.67%18.59%7/30/2025 (Estimated)

Latest CAH, MCK, and RMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q4 2025
McKesson Corporation stock logo
MCK
McKesson
$9.83$10.12+$0.29$10.01$94.00 billion$90.82 billion
5/1/2025Q3 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.15$2.35+$0.20$2.10$55.33 billion$54.88 billion
4/23/2025Q3 2025
ResMed Inc. stock logo
RMD
ResMed
$2.36$2.37+$0.01$2.48$1.28 billion$1.29 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.021.23%N/A31.51%29 Years
McKesson Corporation stock logo
MCK
McKesson
$2.840.39%N/A10.99%17 Years
ResMed Inc. stock logo
RMD
ResMed
$2.120.83%N/A23.79%13 Years

Latest CAH, MCK, and RMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.51071.35%7/1/20257/1/20257/15/2025
5/1/2025
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.710.4%6/2/20256/2/20257/1/2025
4/24/2025
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.530.9%5/8/20255/8/20256/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.94
0.50
McKesson Corporation stock logo
MCK
McKesson
N/A
0.90
0.53
ResMed Inc. stock logo
RMD
ResMed
0.12
3.41
2.49

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
McKesson Corporation stock logo
MCK
McKesson
85.07%
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.09%
McKesson Corporation stock logo
MCK
McKesson
0.11%
ResMed Inc. stock logo
RMD
ResMed
0.71%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,900238.68 million238.46 millionOptionable
McKesson Corporation stock logo
MCK
McKesson
45,000125.11 million124.97 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
9,980146.63 million145.59 millionOptionable

Recent News About These Companies

ResMed: A Sleeping Giant Hiding In Plain Sight

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cardinal Health stock logo

Cardinal Health NYSE:CAH

$164.26 +0.27 (+0.17%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$162.55 -1.71 (-1.04%)
As of 06/24/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

McKesson stock logo

McKesson NYSE:MCK

$721.58 -0.25 (-0.03%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$721.02 -0.56 (-0.08%)
As of 06/24/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

ResMed stock logo

ResMed NYSE:RMD

$256.06 +1.54 (+0.60%)
Closing price 06/24/2025 03:59 PM Eastern
Extended Trading
$257.25 +1.19 (+0.46%)
As of 06/24/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.